Biogen Down Over 7%, Worst Performer in the S&P 500 and Nasdaq 100 So Far Today -- Data Talk
September 09 2021 - 12:11PM
Dow Jones News
Biogen Inc. (BIIB) is currently at $297.78, down $23.77 or
7.39%
-- Would be lowest close since June 4, 2021, when it closed at
$286.14
-- On pace for largest percent decrease since Nov. 9, 2020, when
it fell 28.17%
-- Currently down seven consecutive days; down 13.54% over this
period
-- Longest losing streak since Dec. 24, 2018, when it fell for
eight straight trading days
-- Worst seven day stretch since the seven days ending Nov. 17,
2020, when it fell 24.35%
-- Down 12.14% month-to-date
-- Up 21.61% year-to-date
-- Down 32.08% from its all-time closing high of $438.43 on
March 20, 2015
-- Up 11.73% from 52 weeks ago (Sept. 10, 2020), when it closed
at $266.51
-- Down 28.2% from its 52 week closing high of $414.71 on June
10, 2021
-- Up 26.04% from its 52 week closing low of $236.26 on Nov. 9,
2020
-- Traded as low as $297.52; lowest intraday level since June 7,
2021, when it hit $286.00
-- Down 7.47% at today's intraday low; largest intraday percent
decrease since July 15, 2021, when it fell as much as 8.05%
-- Worst performer in the S&P 500 today
-- Worst performer in the Nasdaq 100 today
All data as of 11:36:55 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 09, 2021 11:56 ET (15:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2023 to Apr 2024